Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer
- 10 August 2016
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 74 (2) , 245-255
Abstract
TNF-related apoptosis-inducing ligand (TRAIL) is a prominent cytokine capable of inducing apoptosis. It can bind to five different cognate receptors, through which diverse intracellular pathways can be activated. TRAIL’s ability to preferentially kill transformed cells makes it a promising potential weapon for targeted tumor therapy. However, recognition of several resistance mechanisms to TRAIL-induced apoptosis has indicated that a thorough understanding of the details of TRAIL biology is still essential before this weapon can be confidently unleashed. Critical to this aim is revealing the functions and regulation mechanisms of TRAIL’s potent death receptor DR5. Although expression and signaling mechanisms of DR5 have been extensively studied, other aspects, such as its subcellular localization, non-signaling functions, and regulation of its membrane transport, have only recently attracted attention. Here, we discuss different aspects of TRAIL/DR5 biology, with a particular emphasis on the factors that seem to influence the cell surface expression pattern of DR5, along with factors that lead to its nuclear localization. Disturbance of this balance apparently affects the sensitivity of cancer cells to TRAIL-mediated apoptosis, thus constituting an eligible target for potential new therapeutic agents.Keywords
Funding Information
- Akdeniz Üniversitesi (TDK-2015-942)
This publication has 121 references indexed in Scilit:
- Membrane Trafficking of Death Receptors: Implications on SignallingInternational Journal of Molecular Sciences, 2013
- BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomasCell Death & Disease, 2013
- Architecture of the human regulatory network derived from ENCODE dataNature, 2012
- A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell DeathMolecular Cell, 2012
- c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistanceCellular Signalling, 2010
- Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancerJournal of Molecular Medicine, 2009
- Trafficking of receptor tyrosine kinases to the nucleusExperimental Cell Research, 2009
- RNA‐binding proteins and post‐transcriptional gene regulationFEBS Letters, 2008
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAILNature Medicine, 2007
- HuR and mRNA stabilityCellular and Molecular Life Sciences, 2001